The Time for DMD Gene Therapy is Now: A Chat with the MDA | BioSpace, page-4

Uboy,
Tellingly, the article linked by George talks about opening the door for combination therapies to deal with downstream events like fibrosis and inflammation. We need to remember that corticosteroids is less a family-friendly door and more trap-door. ATL1102 is looking every bit like a big-sized patio sliding door opening up into a new world of possibilities.

What is further interesting is that the spokesperson for MDA and the founder of the Jett Foundation have reached similar conclusions that the dystrophin drugs can be topped up with anti-fibrotic and anti-inflammatory drugs. Now for the first time they are in reach of a safe and efficacious anti-inflammatory drug that itself operates at the cellular level in the stabilisation and improvement of muscle strength and function. ATL1102 is like an anti-inflammatory drug on steroids.